CLINICAL_TRIALS
trial_result
· 2026-01-20
Clinical Trial Update: Needle-based Percutaneous Ablation of Liver Tumors. [NA]
Summary
A clinical trial evaluating needle-based percutaneous ablation for liver tumors, including hepatocellular carcinoma and metastatic liver cancer, is currently re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: inTumo Therapeutics, Inc. | Conditions: Liver Tumors, HCC - Hepatocellular Carcinoma | NA | Status: RECRUITING